POINT Biopharma Announces Abstract Publication of Dosimetry Data Findings from the Lead-In Cohort of the SPLASH trial in mCRPC at the 2022 SNMMI Mid-Winter & ACNM Annual Meeting
Dosimetry data demonstrated PNT2002 has a favorable and safe dosimetry profile in the patient population…
CORRECTION: Agereh Expands Intelligent Transportation Portfolio with Launch of Smart Door Sensor™ and retains Hillside C&M Inc.
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.